David Kirn - Net Worth and Insider Trading
David Kirn Net Worth
The estimated net worth of David Kirn is at least $26 Million dollars as of 2023-09-24. David Kirn is the CEO of 4D Molecular Therapeutics Inc and owns about 1,859,153 shares of 4D Molecular Therapeutics Inc (FDMT) stock worth over $26 Million. Details can be seen in David Kirn's Latest Holdings Summary section.
Transaction Summary of David Kirn
David Kirn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Kirn owns 1 companies in total, including 4D Molecular Therapeutics Inc (FDMT) .
Click here to see the complete history of David Kirn’s form 4 insider trades.
Insider Ownership Summary of David Kirn
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc | 2023-05-02 | director & Chief Executive Officer |
David Kirn Latest Holdings Summary
David Kirn currently owns a total of 1 stock. David Kirn owns 1,859,153 shares of 4D Molecular Therapeutics Inc (FDMT) as of February 22, 2023, with a value of $26 Million.
Latest Holdings of David Kirn
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FDMT | 4D Molecular Therapeutics Inc | 2023-02-22 | 1,859,153 | 13.91 | 25,860,818 |
Holding Weightings of David Kirn
David Kirn Form 4 Trading Tracker
According to the SEC Form 4 filings, David Kirn has made a total of 3 transactions in 4D Molecular Therapeutics Inc (FDMT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in 4D Molecular Therapeutics Inc is the sale of 34,446 shares on February 22, 2023, which brought David Kirn around $709,932.
Insider Trading History of David Kirn
- 1
David Kirn Trading Performance
David Kirn Ownership Network
Ownership Network List of David Kirn
Ownership Network Relation of David Kirn
David Kirn Owned Company Details
What does 4D Molecular Therapeutics Inc do?
4D Molecular Therapeutics Inc a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built portfolio of gene therapy product candidates focused in three therapeutic areas: ophthalmology (intravitreal vector), cardiology (intravenous vector) and pulmonology (aerosol vector). It has three product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa in a Phase 1/2 clinical trial, 4D-110 for the treatment of choroideremia in a Phase 1 clinical trial, and 4D-310 for the treatment of Fabry disease in a Phase 1/2 clinical trial. Its two IND candidates are 4D-150 for the treatment of wet age-related macular degeneration, and 4D-710 for the treatment of cystic fibrosis lung disease.
Who are the key executives at 4D Molecular Therapeutics Inc?
David Kirn is the director & Chief Executive Officer of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include 10 percent owner Viking Global Opportunities Parent Gp Llc , 10 percent owner Viking Global Investors Lp , and 10 percent owner Ole Andreas Halvorsen .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, David Kirn made 3 insider transaction in 4D Molecular Therapeutics Inc (FDMT) with a net sale of 140,847. Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 11,998 shares made by Scott Bizily , a net purchase of 850,000 shares made by Viking Global Investors Lp , and a net sale of 5,000 shares made by Jacob Chacko .
In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 157,845 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 692,155 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
David Kirn Mailing Address
Above is the net worth, insider trading, and ownership report for David Kirn. You might contact David Kirn via mailing address: C/o 4d Molecular Therapeutics Inc., 5858 Horton Street #455, Emeryville Ca 94608.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
